NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer

BACKGROUND: Robotic radical prostatectomy (RARP) is a first-line curative treatment option for localized prostate cancer. Postoperative erectile dysfunction and urinary incontinence are common associated adverse side effects that can negatively impact patients’ quality of life. Preserving the latera...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinneen, Eoin, Grierson, Jack, Almeida-Magana, Ricardo, Clow, Rosie, Haider, Aiman, Allen, Clare, Heffernan-Ho, Daniel, Freeman, Alex, Briggs, Tim, Nathan, Senthil, Mallett, Susan, Brew-Graves, Chris, Muirhead, Nicola, Williams, Norman R., Pizzo, Elena, Persad, Raj, Aning, Jon, Johnson, Lyndsey, Oxley, Jon, Oakley, Neil, Morgan, Susan, Tahir, Fawzia, Ahmad, Imran, Dutto, Lorenzo, Salmond, Jonathan M., Kelkar, Anand, Kelly, John, Shaw, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306247/
https://www.ncbi.nlm.nih.gov/pubmed/35869497
http://dx.doi.org/10.1186/s13063-022-06421-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306247/
https://www.ncbi.nlm.nih.gov/pubmed/35869497
http://dx.doi.org/10.1186/s13063-022-06421-7

Ejemplares similares